# Multidrug-resistant tuberculosis

*PRI Rank #13 · Topics and Trends in Most Cited Mycobacterium research and diagnosis Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/mycobacterium-research-and-diagnosis/2026/rank-13*

| Field | Value |
| --- | --- |
| Rank | #13 |
| 18m citations | 27 |
| Journal | Clinica Chimica Acta |
| Year | 2024 |
| DOI | 10.1016/j.cca.2024.119701 |
| Corresponding authors | Irkham Irkham |
| Institution | Universitas Padjadjaran, Indonesia |

**Ranking page:** [Topics and Trends in Most Cited Mycobacterium research and diagnosis Papers, Class of 2026](https://pri.pepkio.com/top-papers/mycobacterium-research-and-diagnosis/2026)

**Paper link:** [10.1016/j.cca.2024.119701](https://doi.org/10.1016/j.cca.2024.119701)

## Topics

multidrug-resistant tuberculosis · multidrug-resistant tuberculosis · rifampicin resistance · isoniazid resistance · Mycobacterium tuberculosis · Second-line drugs · extensively drug-resistant tuberculosis · extensively drug-resistant tuberculosis · drug susceptibility testing · treatment regimens · fluoroquinolones · injectable agents · bedaquiline · linezolid · transmission dynamics · treatment outcomes · adverse events · directly observed therapy

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Mycobacterium research and diagnosis Papers, Class of 2026. https://pri.pepkio.com/top-papers/mycobacterium-research-and-diagnosis/2026. Accessed 2026-07-29.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```